Indication

Anaerobic tubo-ovarian abscess

An anaerobic tubo-ovarian abscess is a severe, localized infectious complication of the female upper reproductive tract, typically arising as an advanced manifestation of pelvic inflammatory disease in reproductive-aged females. Read more about Anaerobic tubo-ovarian abscess

80 drugs 59 manufacturers

Advertisement

Drugs that treat it

Common Anaerobic tubo-ovarian abscess therapies.

Showing 28–36 of 80 drugs

CLINDAMYCIN HCL

CLINDAMYCIN SYSTEMIC·SEPSIS CAUSED BY ANAEROBIC BACTERIA·+19
MYLAN INSTITUTI

CLINDAMYCIN HCL

CLINDAMYCIN SYSTEMIC·SEPSIS CAUSED BY ANAEROBIC BACTERIA·+19
RANBAXY/SUN PHA
Filter & compare in the drug finder →Opens the drug finder with Anaerobic tubo-ovarian abscess preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Anaerobic tubo-ovarian abscess.

An anaerobic tubo-ovarian abscess is a severe, localized infectious complication of the female upper reproductive tract, typically arising as an advanced manifestation of pelvic inflammatory disease in reproductive-aged females.

It is characterized by an inflammatory, walled-off collection of purulent material involving the fallopian tube, ovary, and frequently adjacent pelvic structures, driven predominantly or co-infected by anaerobic bacteria such as *Bacteroides fragilis*, *Prevotella*, and *Peptostreptococcus* species.

Pathophysiologically, ascending lower genital tract flora create tissue necrosis, architectural distortion, and localized hypoxia that promote anaerobic proliferation.

Patients typically present with lower abdominal or pelvic pain, fever, purulent cervical discharge, and tender adnexal fullness, carrying critical risks of systemic sepsis, pelvic peritonitis, and chronic infertility if untreated.

Personalize your experience

Follow Anaerobic tubo-ovarian abscess and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it